Glucocorticoid receptors are found intracellularly in almost all tissues. Glucocorticoids enter cells through passive diffusion and form a complex with a receptor protein. This complex then undergoes ...
The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and ...
Prognostic factors and long-term survivors in EGFR-mutated lung cancer: A multi-institutional retrospective analysis. Overall survival (OS) in a u.s. Asian population with stage IV NSCLC with EGFR ...
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial This academic, investigator-initiated ...
Exploring Teclistamab’s Potential in Combination Therapy for Multiple Myeloma: Marc S. Raab, MD, PhD
Marc S. Raab, MD, PhD, discusses the different ways that combination therapy that includes teclistamab can benefit patients with multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results